Genomic Vision

Genomic Vision

Partager

Biotechnology company specialized in molecular diagnostics solutions and in the development of DNA detection tools used for research and in vitro diagnosis

An innovative company in Clinical Diagnosis


Genomic Vision’s technology opens a new perspective for the structural and functional analysis of the genome

The technology combines Molecular Combing, a proprietary technique to untangle single DNA molecules, with a unique detection strategy, the Genomic Morse Code. Genomic Vision’s solution fulfills an unmet medical and research need by enabling the

DNA replication filmed for first time shows how awkward and random genetics is 23/06/2017

Researchers have capture the replication of a single DNA molecule on video for the first time.

DNA replication filmed for first time shows how awkward and random genetics is DNA: It's just like us.

Photos 20/06/2017

Genomic Vision supports the world FSHD Day and the patients, families and physicians it serves every day
https://www.fshsociety.org/

Stéphane Altaba : «Notre objectif est de signer d’autres partenariats» 23/05/2017

Le Revenu – Interview of Stephane Altaba, VP Corporate Development of Genomic Vision following the technological collaboration signed with AstraZeneca in oncology to study WEE1 inhibition using Molecular Combing

Stéphane Altaba : «Notre objectif est de signer d’autres partenariats» La biotech, issue de l’institut Pasteur et spécialisée dans le diagnostic moléculaire, a annoncé, mardi 23 mai, la signature d’un partenariat avec le géant britannique de la pharmacie Astra-Zeneca.

Photos 09/05/2017

Save the date - May 10 - - R&D day - Presentation diagnostic programs

Rare Disease Day 2017 - 28 Feb 28/02/2017

Today is !
Genomic Vision’s supports Rare Disease Day and the FSHD patients, families, and physicians it serves every day.
http://www.rarediseaseday.org/

Rare Disease Day 2017 - 28 Feb The main objective of Rare Disease Day 2017 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.

TCGA study identifies genomic features of cervical cancer 24/01/2017

TCGA study identifies genomic features of cervical cancer
https://lc.cx/JcE5

TCGA study identifies genomic features of cervical cancer Using The Cancer Genome Atlas scientists have identified novel genomic characteristics of cervical cancer that could be used to target therapies

Press Releases | Genomic Vision 10/01/2017

Press Release: Financial information at December 31st, 2016.
Genomic Vision doubles its installed base of FiberVision® platforms and quadruples its sales of products & services.
https://miniurl.be/r-1apg

Press Releases | Genomic Vision Financial information at September 30, 2016 and implementation of a flexible financing via the reserved issuance of convertible notes with warrants

Photos 06/01/2017

Genomic Vision will participate at the Keystone Symposia on Molecular and Cellular Biology Precision Engineering taking place in Colorado.
We look forward to discussing about our solutions for genome engineering https://lc.cx/JimP

CRISPR will be a huge story in 2017. Here are 7 things to look for. 06/01/2017

CRISPR will be a huge story in 2017. Here are 7 things to look for. The gene-editing tool’s potential to upend science is dizzying.

Photos 30/11/2016

Come visit us at at in . http://www.pasteur-network-meeting2016.org/

Startegy 2016 | Genomic Vision 25/03/2016

Maximization of Molecular Combing’s potential on the Life Sciences Research Tools market http://goo.gl/ilfCr1

Startegy 2016 | Genomic Vision > Maximization of molecular combing’s potential: targeting of the major and accessible Life Sciences Research Tools (LSRT) market

Vous voulez que votre entreprise soit Société D'ingénierie la plus cotée à Paris ?
Cliquez ici pour réclamer votre Listage Commercial.

Adresse


80 Rue Des Meuniers
Paris
92220